Results 31 to 40 of about 189 (145)

Kernenergie

, 2021
Michiel Köhne, Elisabet Dueholm Rasch
openaire   +2 more sources

Thanks to Our 2016 Reviewers

, 2017
Vadose Zone Journal, Volume 16, Issue 4, Page 1-4, April 2017.
wiley   +1 more source

[Parliamentary technology assessment and risk communication]. [PDF]

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2022
Grunwald A.
europepmc   +1 more source

Kernenergie in Nederland

, 2022
Beleid kan soms snel veranderen. In 2017 had geen enkele politieke partij een passage in het verkiezingsprogramma over het bouwen van nieuwe kerncentrales. Vier jaar later werd in het nieuwe regeerakkoord de bouw van twee nieuwe centrales aangekondigd.
openaire   +1 more source

[Debating the "Unresolved Potential Dangers of Genetic Engineering". Public Science, Strategies of Enactment and Performance of Science in the Context of the West German Debate of Genetic Engineering]. [PDF]

NTM, 2022
Schmidt AM.
europepmc   +1 more source

Corrigendum: Immunological Changes During Space Travel: A Ground-Based Evaluation of the Impact of Neutron Dose Rate on Plasma Cytokine Levels in Human Whole Blood Cultures

Frontiers in Physics, 2021
Randall Fisher, Bjorn Baselet, Randy Vermeesen, Marjan Moreels, Sarah Baatout, Farzana Rahiman, Xanthene Miles, Shankari Nair, Peter du Plessis, Monique Engelbrecht, Monique Engelbrecht, Roya J. Ndimba, Julie Bolcaen, Jaime Nieto-Camero, Evan de Kock, Charlot Vandevoorde   +15 more
doaj   +1 more source

Beyond the Failure of Direct-Matching in Keyword Evaluation: A Sketch of a Graph Based Solution. [PDF]

Front Artif Intell, 2022
Kölbl M, Kyogoku Y, Philipp JN, Richter M, Rietdorf C, Yousef T.   +5 more
europepmc   +1 more source

Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial. [PDF]

J Clin Oncol, 2022
Bauer S, Jones RL, Blay JY, Gelderblom H, George S, Schöffski P, von Mehren M, Zalcberg JR, Kang YK, Razak AA, Trent J, Attia S, Le Cesne A, Su Y, Meade J, Wang T, Sherman ML, Ruiz-Soto R, Heinrich MC.   +18 more
europepmc   +1 more source

[EN] Editorial

Technikfolgenabschätzung – Theorie und Praxis, 2012
Armin Grunwald
doaj   +1 more source

Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib. [PDF]

Ann Oncol, 2023
Serrano C, Bauer S, Gómez-Peregrina D, Kang YK, Jones RL, Rutkowski P, Mir O, Heinrich MC, Tap WD, Newberry K, Grassian A, Shi H, Bialick S, Schöffski P, Pantaleo MA, von Mehren M, Trent JC, George S.   +17 more
europepmc   +1 more source